Emmessar Biotech & Nutrition Limited (EMMESSA.BO)
INR 37.25
(8.13%)
INR 37.25
(8.13%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -10.81 Million INR | -59.35% |
| 2022 | -6.9 Million INR | 36.66% |
| 2021 | -10.71 Million INR | -226.29% |
| 2020 | 8.48 Million INR | 698.54% |
| 2019 | -4.05 Million INR | 59.66% |
| 2018 | -6.38 Million INR | 15.48% |
| 2017 | -4.15 Million INR | -271.91% |
| 2016 | 2.4 Million INR | -76.36% |
| 2015 | 1 Million INR | 820.15% |
| 2014 | -1.42 Million INR | -271.19% |
| 2013 | -382.75 Thousand INR | 66.6% |
| 2012 | -1.14 Million INR | -368.95% |
| 2011 | 426.05 Thousand INR | 121.14% |
| 2010 | -2.01 Million INR | -165.52% |
| 2009 | -759.12 Thousand INR | -330.19% |
| 2008 | 329.78 Thousand INR | 147.66% |
| 2007 | -692 Thousand INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -2.74 Million INR | 29.29% |
| 2023 FY | - INR | -59.35% |
| 2023 Q2 | -2.15 Million INR | 21.19% |
| 2023 Q4 | -3.92 Million INR | -90.44% |
| 2023 Q1 | -2.73 Million INR | -81.47% |
| 2023 Q3 | -2.06 Million INR | 4.32% |
| 2022 Q4 | -1.5 Million INR | 12.14% |
| 2022 Q2 | -2.04 Million INR | -34.63% |
| 2022 Q1 | -1.51 Million INR | 57.32% |
| 2022 FY | - INR | 36.66% |
| 2022 Q3 | -1.71 Million INR | 16.02% |
| 2021 Q4 | -3.55 Million INR | -65.05% |
| 2021 Q3 | -2.15 Million INR | 4.4% |
| 2021 Q2 | -2.25 Million INR | 18.5% |
| 2021 Q1 | -2.76 Million INR | -128.25% |
| 2021 FY | - INR | -226.29% |
| 2020 Q4 | 9.77 Million INR | 1402.0% |
| 2020 Q3 | -751 Thousand INR | -176.4% |
| 2020 Q2 | 983 Thousand INR | 163.67% |
| 2020 Q1 | -1.54 Million INR | -251.72% |
| 2020 FY | - INR | 698.54% |
| 2019 Q4 | 1.01 Million INR | 179.75% |
| 2019 Q1 | 605 Thousand INR | 139.06% |
| 2019 Q3 | -1.27 Million INR | 25.81% |
| 2019 FY | - INR | 59.66% |
| 2019 Q2 | -1.72 Million INR | -384.3% |
| 2018 Q1 | -1.11 Million INR | 41.71% |
| 2018 Q3 | -1.19 Million INR | 52.9% |
| 2018 Q4 | -1.54 Million INR | -29.94% |
| 2018 FY | - INR | 15.48% |
| 2018 Q2 | -2.53 Million INR | -127.81% |
| 2017 Q4 | -1.9 Million INR | -82.04% |
| 2017 Q2 | -471 Thousand INR | 50.99% |
| 2017 FY | - INR | -271.91% |
| 2017 Q1 | -961 Thousand INR | -1984.31% |
| 2017 Q3 | -1.04 Million INR | -122.29% |
| 2016 Q4 | 51 Thousand INR | -98.79% |
| 2016 FY | - INR | -76.36% |
| 2016 Q3 | 4.22 Million INR | 521.03% |
| 2016 Q2 | 680 Thousand INR | -82.18% |
| 2016 Q1 | 3.81 Million INR | 1248.41% |
| 2015 FY | - INR | 820.15% |
| 2015 Q3 | 208 Thousand INR | 188.51% |
| 2015 Q4 | 283 Thousand INR | 36.06% |
| 2015 Q1 | 2.44 Million INR | 373.23% |
| 2015 Q2 | -235 Thousand INR | -109.62% |
| 2014 Q3 | 990 Thousand INR | 281.99% |
| 2014 Q1 | -482 Thousand INR | -2.8% |
| 2014 FY | - INR | -271.19% |
| 2014 Q2 | -544 Thousand INR | -12.86% |
| 2014 Q4 | -894.1 Thousand INR | -190.31% |
| 2013 Q3 | 269 Thousand INR | 120.27% |
| 2013 Q4 | -468.85 Thousand INR | -274.3% |
| 2013 FY | - INR | 66.6% |
| 2013 Q1 | 1.78 Million INR | 209.46% |
| 2013 Q2 | -1.32 Million INR | -174.43% |
| 2012 Q4 | -1.62 Million INR | -481.47% |
| 2012 Q1 | 413 Thousand INR | -67.12% |
| 2012 FY | - INR | -368.95% |
| 2012 Q3 | 427 Thousand INR | 219.61% |
| 2012 Q2 | -357 Thousand INR | -186.44% |
| 2011 Q4 | 1.25 Million INR | 31301.4% |
| 2011 Q3 | 4000.00 INR | 0.0% |
| 2011 FY | - INR | 121.14% |
| 2010 FY | - INR | -165.52% |
| 2009 FY | - INR | -330.19% |
| 2008 Q4 | 226 Thousand INR | 0.0% |
| 2008 FY | - INR | 147.66% |
| 2007 FY | - INR | 0.0% |
| 2007 Q4 | 840 Thousand INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| ANG Lifesciences India Limited | 90.66 Million INR | 111.932% |
| DECIPHER LABS LIMITED | -2.72 Million INR | -297.721% |
| Ishita Drugs and Industries Limited | 11.88 Million INR | 190.999% |
| Jenburkt Pharmaceuticals Limited | 377.86 Million INR | 102.863% |
| Patidar Buildcon Limited | -5.52 Million INR | -95.765% |
| Sanjivani Paranteral Limited. | 87.58 Million INR | 112.352% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | -2564.532% |
| Source Natural Foods and Herbal Supplements Limited | 44.8 Million INR | 124.145% |
| Sunil Healthcare Limited | 93.07 Million INR | 111.622% |
| MedPlus Health Services Limited | 3.94 Billion INR | 100.275% |
| KIMIA BIOSCIENCES LIMITED | 11.58 Million INR | 193.387% |
| Add-Shop E-Retail Limited | 82.61 Million INR | 113.094% |
| Bacil Pharma Limited | -569.32 Thousand INR | -1800.162% |
| BDH Industries Limited | 124.27 Million INR | 108.705% |
| Beryl Drugs Limited | 26.63 Million INR | 140.61% |
| Cian Healthcare Limited | 122.56 Million INR | 108.826% |
| Concord Drugs Limited | 40.52 Million INR | 126.698% |
| Deccan Health Care Limited | 37.5 Million INR | 128.843% |
| Gujarat Terce Laboratories Limited | 15.87 Million INR | 168.136% |
| Gujarat Themis Biosyn Limited | 830.99 Million INR | 101.302% |
| Medi-Caps Limited | 4.77 Million INR | 326.745% |
| Parmax Pharma Limited | 22.93 Million INR | 147.163% |
| Sastasundar Ventures Limited | -203.51 Million INR | 94.684% |
| Smruthi Organics Limited | 120.31 Million INR | 108.992% |
| SUDARSHAN PHARMA INDUSTRIES LI | 254.17 Million INR | 104.256% |
| Phaarmasia Limited | -1.58 Million INR | -583.818% |
| Syschem (India) Limited | 70.4 Million INR | 115.366% |
| Transchem Limited | 56.61 Million INR | 119.109% |
| Trinity League India Limited | -26.25 Million INR | 58.793% |
| Tyche Industries Limited | 128.2 Million INR | 108.438% |
| Vista Pharmaceuticals Limited | -32.37 Million INR | 66.589% |
| Zenith Healthcare Limited | 4.98 Million INR | 316.881% |
| Chemo Pharma Laboratories Limited | 16.51 Million INR | 165.492% |
| Colinz Laboratories Limited | 5.42 Million INR | 299.3% |
| Denis Chem Lab Limited | 224.84 Million INR | 104.811% |
| Hindustan Bio Sciences Limited | 638.75 Thousand INR | 1793.61% |
| Kwality Pharmaceuticals Limited | 610.44 Million INR | 101.772% |
| Makers Laboratories Limited | 25.81 Million INR | 141.911% |
| Panchsheel Organics Limited | 189.36 Million INR | 105.713% |
| Parnax Lab Limited | 243.59 Million INR | 104.441% |
| PRAVEG LIMITED | 321.43 Million INR | 103.366% |
| Mercury Laboratories Limited | 101.18 Million INR | 110.691% |
| Trident Lifeline Limited | 102.69 Million INR | 110.534% |
| Vikram Thermo (India) Limited | 386.92 Million INR | 102.796% |
| Vivanza Biosciences Limited | 11.2 Million INR | 196.555% |
| Zenlabs Ethica Limited | 27.09 Million INR | 139.925% |
| SHELTER PHARMA LIMITED | 89.01 Million INR | 112.154% |
| Vasundhara Rasayans Limited | 84.22 Million INR | 112.844% |
| Bharat Immunologicals & Biologicals Corporation Limited | -151.05 Million INR | 92.838% |
| Roopa Industries Limited | 55.7 Million INR | 119.422% |
| PANJON LTD. | 4.08 Million INR | 364.563% |
| Pharmaids Pharmaceuticals Limited | -123.28 Million INR | 91.225% |
| TIAAN CONSUMER LIMITED | -19.05 Million INR | 43.219% |
| Anuh Pharma Limited | 878.5 Million INR | 101.231% |
| Crestchem Limited | 30.33 Million INR | 135.663% |
| Sandu Pharmaceuticals Limited | 27.19 Million INR | 139.782% |
| Fredun Pharmaceuticals Limited | 388.97 Million INR | 102.781% |
| Trimurthi Limited | -2.47 Million INR | -336.472% |
| Shukra Pharmaceuticals Limited | 216.59 Million INR | 104.995% |
| Norris Medicines Limited | -1.78 Million INR | -506.341% |
| Veerhealth Care Limited | 15.99 Million INR | 167.634% |
| Lactose (India) Limited | 201.22 Million INR | 105.376% |
| OXYGENTA PHARMACEUTICAL LIMITE | -96.17 Million INR | 88.751% |
| Ambalal Sarabhai Enterprises Limited | 170.57 Million INR | 106.342% |
| Gennex Laboratories Limited | 219.35 Million INR | 104.932% |
| Godavari Drugs Limited | 134.62 Million INR | 108.036% |
| Zenotech Laboratories Limited | 172.64 Million INR | 106.266% |
| Shree Ganesh Remedies Limited | 448.77 Million INR | 102.411% |
| Bharat Parenterals Limited | 265.74 Million INR | 104.071% |
| Coral Laboratories Limited | 227.07 Million INR | 104.764% |
| Evoq Remedies Limited | 6.18 Million INR | 274.823% |
| Kerala Ayurveda Limited | 70.78 Million INR | 115.282% |
| KOBO BIOTECH LIMITED | -8.57 Million INR | -26.187% |
| Natural Capsules Limited | 219.9 Million INR | 104.92% |
| Auro Laboratories Limited | 121.73 Million INR | 108.886% |